BAWANG GROUP (01338) issues a profit warning, expecting half-year profits of about 1 million to 2 million yuan, turning from loss to profit year-on-year.

12:28 18/08/2026

BaWang Group (01338) announced that the Group expects to achieve a slight operating profit in the first half of 2026, amounting to approximately RMB 1 million to RMB 2 million, while for the six months ending June 30, 2025, it anticipates an operating loss of approximately RMB 2.3 million.

BAWANG GROUP (01338) announced that the group expects to achieve a slight operating profit in the first half of 2026, amounting to approximately RMB 1 million to RMB 2 million, while it incurred an operating loss of about RMB 2.3 million for the six months ending June 30, 2025. Despite a slight decline in group revenue, the group has turned a loss into a profit in the first half of 2026, primarily due to the following reductions in sales costs: a decrease in packaging material costs; cost savings achieved by using electricity generated from the group's rooftop photovoltaic panels in production; and a reduction in rent for the groups operating premises. These factors collectively contributed to an improvement in the group's gross profit for the first half of 2026 compared to the same period in 2025.

CSC DEVELOPMENT (00830) will distribute an interim dividend of HK$0.018 per share on October 30 this year.

361 DEGREES (01361) will distribute an interim dividend of HKD 0.222 per share on September 15.

TEDA BIOMEDICAL (08189) announces a profit alert, expecting a net profit attributable to shareholders of approximately 7 million to 10 million yuan for the interim period, marking a turnaround from loss to profit compared to the same period last year.

CSC DEVELOPMENT (00830) will distribute an interim dividend of HK$0.018 per share on October 30 this year.

361 DEGREES (01361) will distribute an interim dividend of HKD 0.222 per share on September 15.